Long-Acting PEGylated Growth Hormone in Children with Idiopathic Short Stature: 2-Year Results
Once-weekly PEG-rhGH in children with ISS showed sustained efficacy over 2 years in all assessed height-based outcomes. Treatment remained safe and well tolerated with no new safety signals.
Authors
- Ruoqian Cheng (ORCID: https://orcid.org/0000-0001-5779-7848)
- FEIHONG LUO
- Lulian Xu
- Linqi Chen (ORCID: https://orcid.org/0000-0002-1763-630X)
- Xu Xu (ORCID: https://orcid.org/0000-0002-9019-8449)
- Xiuli Chen (ORCID: https://orcid.org/0000-0002-2576-4256)
- GUANPING DONG
- Qiao Shi
- C X Gong
- Yaping Ma
- Ling Hou
- Xiaoping Luo
- Haihong Gong
- Yu Yang
- Chang Su
- Sha Zhao
- Pin Li
- Liya Xu
- Yan Zhong
- Jinling Zhao
- Hongwei Du
- Lina Zhang
- Xuefeng Chen
Institutions
- Jiangnan University (CN)
- Jilin University (CN)
- Soochow University (CN)
- Children's Hospital of Zhejiang University (CN)
- Wuxi Fourth People's Hospital (CN)
- First Hospital of Jilin University (CN)
- Hunan Children's Hospital (CN)
- Beijing Children’s Hospital (CN)
- Jiangxi Provincial Children's Hospital (CN)
- Children's Hospital of Suzhou University (CN)
- Jiangsu Province Hospital (CN)
- First Affiliated Hospital of Soochow University (CN)
- Children's Hospital of Fudan University (CN)
- Shanghai Children's Hospital (CN)
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Hormone Research in Paediatrics
- Published
- 2026-02-03
- DOI
- https://doi.org/10.1159/000550510
- Primary Topic
- Growth Hormone and Insulin-like Growth Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00